Agoston Agoston, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Esophageal Neoplasms | 17 | 2023 | 1581 | 2.220 |
Why?
|
Barrett Esophagus | 10 | 2023 | 494 | 1.750 |
Why?
|
Adenocarcinoma | 13 | 2023 | 6347 | 1.080 |
Why?
|
Esophagitis, Peptic | 3 | 2018 | 77 | 0.880 |
Why?
|
Esophagectomy | 4 | 2021 | 447 | 0.770 |
Why?
|
Esophagus | 6 | 2018 | 1017 | 0.740 |
Why?
|
Precancerous Conditions | 4 | 2023 | 971 | 0.600 |
Why?
|
Thrombocytosis | 1 | 2017 | 81 | 0.590 |
Why?
|
Mucins | 1 | 2020 | 564 | 0.570 |
Why?
|
Paraneoplastic Syndromes | 1 | 2017 | 150 | 0.540 |
Why?
|
Stomach Neoplasms | 5 | 2019 | 1327 | 0.530 |
Why?
|
Models, Anatomic | 1 | 2018 | 690 | 0.480 |
Why?
|
Gastritis, Atrophic | 1 | 2013 | 31 | 0.470 |
Why?
|
Epithelial Cells | 5 | 2018 | 3678 | 0.470 |
Why?
|
Neoadjuvant Therapy | 4 | 2021 | 2721 | 0.470 |
Why?
|
Gastric Mucosa | 1 | 2013 | 598 | 0.370 |
Why?
|
Pilomatrixoma | 1 | 2010 | 23 | 0.370 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2010 | 245 | 0.350 |
Why?
|
Hair Diseases | 1 | 2010 | 74 | 0.350 |
Why?
|
Gastroesophageal Reflux | 4 | 2018 | 782 | 0.350 |
Why?
|
Stomach | 1 | 2013 | 697 | 0.340 |
Why?
|
Trisomy | 1 | 2010 | 266 | 0.330 |
Why?
|
Wound Healing | 1 | 2018 | 2781 | 0.290 |
Why?
|
DNA Modification Methylases | 1 | 2007 | 206 | 0.280 |
Why?
|
Ubiquitin-Protein Ligase Complexes | 1 | 2007 | 168 | 0.280 |
Why?
|
Carcinoma | 4 | 2023 | 2374 | 0.250 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 2 | 2019 | 379 | 0.230 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2018 | 713 | 0.230 |
Why?
|
Retinoblastoma Protein | 1 | 2007 | 701 | 0.230 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2018 | 2948 | 0.220 |
Why?
|
Calcium-Binding Proteins | 1 | 2007 | 1081 | 0.210 |
Why?
|
Granuloma, Foreign-Body | 1 | 2021 | 45 | 0.200 |
Why?
|
Carcinoma, Verrucous | 1 | 2021 | 23 | 0.200 |
Why?
|
Esophagogastric Junction | 2 | 2015 | 312 | 0.200 |
Why?
|
Anastomosis, Surgical | 3 | 2019 | 985 | 0.180 |
Why?
|
Gadolinium DTPA | 2 | 2001 | 836 | 0.180 |
Why?
|
Exocrine Glands | 1 | 2020 | 50 | 0.180 |
Why?
|
Keratins | 1 | 2021 | 515 | 0.180 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2019 | 48 | 0.170 |
Why?
|
Bile Acids and Salts | 2 | 2018 | 353 | 0.170 |
Why?
|
Microsatellite Instability | 3 | 2019 | 678 | 0.170 |
Why?
|
Smad4 Protein | 1 | 2019 | 163 | 0.170 |
Why?
|
DNA Mismatch Repair | 2 | 2019 | 424 | 0.160 |
Why?
|
Colonic Polyps | 1 | 2023 | 542 | 0.160 |
Why?
|
Gallbladder | 1 | 2019 | 301 | 0.160 |
Why?
|
Esophagoscopy | 2 | 2018 | 390 | 0.150 |
Why?
|
Histoplasmosis | 1 | 2018 | 66 | 0.150 |
Why?
|
SOX9 Transcription Factor | 1 | 2018 | 146 | 0.150 |
Why?
|
Proportional Hazards Models | 3 | 2017 | 12344 | 0.150 |
Why?
|
HMGA2 Protein | 1 | 2017 | 123 | 0.150 |
Why?
|
Sigmoid Diseases | 1 | 2017 | 50 | 0.150 |
Why?
|
Gastrectomy | 1 | 2021 | 652 | 0.150 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2015 | 9185 | 0.150 |
Why?
|
Ulcer | 1 | 2018 | 209 | 0.150 |
Why?
|
Colon, Sigmoid | 1 | 2017 | 118 | 0.140 |
Why?
|
Magnetics | 1 | 2019 | 609 | 0.140 |
Why?
|
Metaplasia | 2 | 2014 | 313 | 0.140 |
Why?
|
Ki-67 Antigen | 1 | 2018 | 644 | 0.140 |
Why?
|
Repressor Proteins | 1 | 2007 | 3020 | 0.130 |
Why?
|
Triazenes | 1 | 2015 | 8 | 0.130 |
Why?
|
Cell Cycle Proteins | 1 | 2007 | 3444 | 0.130 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3585 | 0.130 |
Why?
|
Mucous Membrane | 2 | 2016 | 670 | 0.130 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2015 | 82 | 0.130 |
Why?
|
Colonic Neoplasms | 2 | 2017 | 2542 | 0.130 |
Why?
|
Platelet Count | 1 | 2017 | 780 | 0.120 |
Why?
|
Disease Progression | 4 | 2023 | 13256 | 0.120 |
Why?
|
Biopsy | 5 | 2018 | 6756 | 0.120 |
Why?
|
Breast Neoplasms | 6 | 2017 | 20774 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2018 | 2940 | 0.110 |
Why?
|
SOXB1 Transcription Factors | 1 | 2015 | 284 | 0.110 |
Why?
|
Jejunum | 1 | 2015 | 480 | 0.110 |
Why?
|
Epithelium | 1 | 2018 | 1680 | 0.110 |
Why?
|
Remission Induction | 2 | 2015 | 2384 | 0.110 |
Why?
|
Liver Regeneration | 1 | 2014 | 210 | 0.110 |
Why?
|
Iodide Peroxidase | 1 | 2014 | 293 | 0.110 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2011 | 26 | 0.100 |
Why?
|
Catheter Ablation | 2 | 2016 | 2746 | 0.100 |
Why?
|
Contrast Media | 3 | 2011 | 5295 | 0.100 |
Why?
|
Nuclear Proteins | 2 | 2017 | 5851 | 0.100 |
Why?
|
Time Factors | 8 | 2021 | 40054 | 0.100 |
Why?
|
Aged | 16 | 2021 | 162944 | 0.100 |
Why?
|
Middle Aged | 19 | 2021 | 213127 | 0.100 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2021 | 3471 | 0.100 |
Why?
|
Humans | 41 | 2023 | 742088 | 0.100 |
Why?
|
Aged, 80 and over | 11 | 2021 | 57683 | 0.100 |
Why?
|
STAT3 Transcription Factor | 1 | 2015 | 874 | 0.100 |
Why?
|
Female | 26 | 2021 | 379592 | 0.100 |
Why?
|
DNA Mutational Analysis | 2 | 2016 | 4187 | 0.090 |
Why?
|
Skin Neoplasms | 1 | 2010 | 5662 | 0.090 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 1114 | 0.090 |
Why?
|
Chromosome Banding | 1 | 2010 | 278 | 0.090 |
Why?
|
Hyperplasia | 1 | 2013 | 1183 | 0.090 |
Why?
|
Carcinoma in Situ | 1 | 2016 | 802 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2022 | 1585 | 0.090 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1337 | 0.090 |
Why?
|
Male | 23 | 2021 | 349538 | 0.090 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 2906 | 0.090 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2015 | 859 | 0.090 |
Why?
|
Liver | 2 | 2015 | 7470 | 0.080 |
Why?
|
Mucin-1 | 1 | 2013 | 543 | 0.080 |
Why?
|
Colitis | 1 | 2017 | 1149 | 0.080 |
Why?
|
Cell Differentiation | 3 | 2018 | 11470 | 0.080 |
Why?
|
Immunohistochemistry | 5 | 2017 | 11363 | 0.080 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2417 | 0.080 |
Why?
|
Neuroendocrine Tumors | 1 | 2014 | 594 | 0.080 |
Why?
|
Trans-Activators | 1 | 2018 | 2924 | 0.080 |
Why?
|
Antirheumatic Agents | 1 | 2018 | 1335 | 0.080 |
Why?
|
Epigenesis, Genetic | 2 | 2014 | 3639 | 0.080 |
Why?
|
Cell Line, Tumor | 4 | 2016 | 16665 | 0.080 |
Why?
|
Hepatocytes | 1 | 2014 | 1209 | 0.080 |
Why?
|
Colon | 1 | 2015 | 1773 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2018 | 3502 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2018 | 10472 | 0.070 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 8300 | 0.070 |
Why?
|
Transcription Factors | 2 | 2017 | 12164 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2022 | 4029 | 0.070 |
Why?
|
Nitric Oxide | 1 | 2015 | 2128 | 0.070 |
Why?
|
Genomics | 2 | 2023 | 5692 | 0.070 |
Why?
|
Risk Factors | 6 | 2023 | 72145 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2017 | 3465 | 0.070 |
Why?
|
Cohort Studies | 3 | 2017 | 40450 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2014 | 1899 | 0.070 |
Why?
|
Adult | 12 | 2021 | 213712 | 0.070 |
Why?
|
Treatment Outcome | 6 | 2021 | 62966 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3070 | 0.060 |
Why?
|
Stem Cells | 1 | 2018 | 3563 | 0.060 |
Why?
|
Cell Line | 4 | 2018 | 15994 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6891 | 0.060 |
Why?
|
Th1 Cells | 1 | 2009 | 1056 | 0.060 |
Why?
|
Th2 Cells | 1 | 2009 | 1049 | 0.060 |
Why?
|
Retrospective Studies | 7 | 2021 | 77098 | 0.060 |
Why?
|
Immunoblotting | 1 | 2007 | 1683 | 0.060 |
Why?
|
RNA, Messenger | 4 | 2022 | 13029 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2023 | 6754 | 0.060 |
Why?
|
Histone Deacetylases | 1 | 2008 | 729 | 0.060 |
Why?
|
Ubiquitin | 1 | 2008 | 849 | 0.050 |
Why?
|
RNA Stability | 1 | 2005 | 322 | 0.050 |
Why?
|
Chromosomal Instability | 1 | 2023 | 184 | 0.050 |
Why?
|
Prognosis | 3 | 2018 | 29010 | 0.050 |
Why?
|
Arthritis, Rheumatoid | 1 | 2018 | 3695 | 0.050 |
Why?
|
Boston | 1 | 2015 | 9305 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4553 | 0.050 |
Why?
|
Mitochondria | 1 | 2015 | 3520 | 0.050 |
Why?
|
Animals | 11 | 2019 | 168561 | 0.050 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2008 | 1333 | 0.050 |
Why?
|
Signal Transduction | 4 | 2018 | 23387 | 0.050 |
Why?
|
Proton Pump Inhibitors | 2 | 2016 | 521 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 4 | 2011 | 35342 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2009 | 2524 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4751 | 0.040 |
Why?
|
Diagnosis, Differential | 4 | 2017 | 12958 | 0.040 |
Why?
|
Transfection | 1 | 2007 | 5892 | 0.040 |
Why?
|
Muscle Neoplasms | 1 | 1999 | 139 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2015 | 4823 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 12071 | 0.040 |
Why?
|
Histoplasma | 1 | 2018 | 41 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9274 | 0.040 |
Why?
|
Neoplasms | 1 | 2007 | 21596 | 0.040 |
Why?
|
RNA, Small Interfering | 1 | 2007 | 3504 | 0.040 |
Why?
|
Carcinoma, Lobular | 1 | 2002 | 484 | 0.040 |
Why?
|
Swine | 2 | 2019 | 5934 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 2014 | 18112 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2014 | 8425 | 0.040 |
Why?
|
DNA Methylation | 2 | 2009 | 4282 | 0.040 |
Why?
|
2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2016 | 35 | 0.030 |
Why?
|
Neoplasm Staging | 3 | 2017 | 11001 | 0.030 |
Why?
|
Organometallic Compounds | 1 | 1999 | 665 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2016 | 408 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2018 | 544 | 0.030 |
Why?
|
Omeprazole | 1 | 2016 | 112 | 0.030 |
Why?
|
Up-Regulation | 2 | 2018 | 4211 | 0.030 |
Why?
|
Cell Movement | 2 | 2018 | 5212 | 0.030 |
Why?
|
Adenoma, Islet Cell | 1 | 2014 | 82 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2023 | 3612 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2016 | 376 | 0.030 |
Why?
|
Carbon Tetrachloride | 1 | 2014 | 64 | 0.030 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2002 | 1101 | 0.030 |
Why?
|
Toxins, Biological | 1 | 2014 | 66 | 0.030 |
Why?
|
Microsatellite Repeats | 1 | 2016 | 800 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2015 | 528 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 2015 | 898 | 0.030 |
Why?
|
Culture Media | 1 | 2015 | 902 | 0.030 |
Why?
|
Young Adult | 2 | 2019 | 56350 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2005 | 13814 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 627 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2015 | 731 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2016 | 628 | 0.030 |
Why?
|
Pressure | 1 | 2015 | 1203 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 704 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13655 | 0.030 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1950 | 0.030 |
Why?
|
Methylation | 1 | 2014 | 1107 | 0.030 |
Why?
|
Withholding Treatment | 1 | 2016 | 598 | 0.030 |
Why?
|
beta Catenin | 1 | 2016 | 1058 | 0.020 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2019 | 987 | 0.020 |
Why?
|
Eosinophils | 1 | 2016 | 953 | 0.020 |
Why?
|
Cadherins | 1 | 2016 | 906 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2017 | 2638 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2015 | 890 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2015 | 656 | 0.020 |
Why?
|
Gene Amplification | 1 | 2015 | 1062 | 0.020 |
Why?
|
Herpesvirus 4, Human | 1 | 2016 | 1040 | 0.020 |
Why?
|
Rats | 2 | 2018 | 24265 | 0.020 |
Why?
|
Mice | 5 | 2016 | 81045 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1655 | 0.020 |
Why?
|
Necrosis | 1 | 2014 | 1643 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2372 | 0.020 |
Why?
|
Point Mutation | 1 | 2015 | 1624 | 0.020 |
Why?
|
Gastritis | 1 | 2011 | 191 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2017 | 9639 | 0.020 |
Why?
|
Organ Specificity | 1 | 2014 | 2003 | 0.020 |
Why?
|
Cisplatin | 1 | 2015 | 1637 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2015 | 9410 | 0.020 |
Why?
|
Mutation | 3 | 2018 | 29717 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3587 | 0.020 |
Why?
|
Lymphocytes | 1 | 2016 | 2614 | 0.020 |
Why?
|
Helicobacter Infections | 1 | 2011 | 385 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2018 | 18006 | 0.020 |
Why?
|
Paclitaxel | 1 | 2015 | 1707 | 0.020 |
Why?
|
Cross-Cultural Comparison | 1 | 2011 | 651 | 0.020 |
Why?
|
Child, Preschool | 1 | 2010 | 40955 | 0.020 |
Why?
|
Risk Assessment | 2 | 2021 | 23320 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2001 | 4029 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2014 | 14554 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6534 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 17400 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2015 | 2938 | 0.020 |
Why?
|
China | 1 | 2011 | 2246 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2015 | 5062 | 0.020 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2008 | 434 | 0.020 |
Why?
|
Base Sequence | 1 | 2016 | 12797 | 0.020 |
Why?
|
Hydroxamic Acids | 1 | 2008 | 495 | 0.020 |
Why?
|
Chromatin | 1 | 2016 | 2917 | 0.020 |
Why?
|
Body Weight | 1 | 2015 | 4664 | 0.020 |
Why?
|
Histones | 1 | 2014 | 2597 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2007 | 11039 | 0.010 |
Why?
|
Recovery of Function | 1 | 2014 | 2924 | 0.010 |
Why?
|
Neutrophils | 1 | 2016 | 3711 | 0.010 |
Why?
|
Patient Selection | 1 | 2015 | 4214 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2011 | 2013 | 0.010 |
Why?
|
Genetic Markers | 1 | 2009 | 2633 | 0.010 |
Why?
|
Mastectomy, Modified Radical | 1 | 2002 | 62 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4147 | 0.010 |
Why?
|
Child | 1 | 2010 | 77478 | 0.010 |
Why?
|
Adolescent | 1 | 2010 | 85649 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2011 | 2658 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2009 | 3199 | 0.010 |
Why?
|
Gene Silencing | 1 | 2007 | 1538 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 21719 | 0.010 |
Why?
|
Gene Deletion | 1 | 2008 | 2751 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 7716 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2008 | 1989 | 0.010 |
Why?
|
Indoles | 1 | 2008 | 1834 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15056 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18355 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2008 | 2968 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2009 | 5519 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16331 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 3800 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12773 | 0.010 |
Why?
|
Mastectomy, Segmental | 1 | 2002 | 955 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2009 | 9735 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12220 | 0.010 |
Why?
|
Capillary Permeability | 1 | 1999 | 798 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2011 | 6259 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 1999 | 2085 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 53187 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2009 | 19223 | 0.010 |
Why?
|
Rabbits | 1 | 1999 | 4886 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39004 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2014 | 15244 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 21821 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20086 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2002 | 19862 | 0.000 |
Why?
|
United States | 1 | 2011 | 69693 | 0.000 |
Why?
|